Anthony Hunt sold $4.1M of Repligen (RGEN)

Executed Mar 17 2025, disclosed Mar 19 2025, 2 days later.

Value, as filed

$4.1M

26,596 sh across 4 lots

Executed

Mar 17 2025

the trade date, as filed

Disclosed

Mar 19 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Anthony Hunt Director profile →

Anthony Hunt (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Repligen Corporation (RGEN). The largest single filing was $3.8M of RGEN (24,536 sh across 4 lots, as filed), executed Nov 12 2025.

The name

RGEN

Repligen Corporation RGEN · Healthcare · 19 filings in 24 months ticker →

Healthcare · Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Anthony Hunt in RGEN

RGENSALE Repligen Corporation $3.1M
20,000 sh across 7 lots
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET RGENSALE Repligen Corporation $3.8M
24,536 sh across 4 lots
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET RGENSALE Repligen Corporation $3.5M
29,015 sh across 5 lots
Exec Sep 10 2025
Filed Sep 11 2025 · 5:30 PM ET RGENSALE Repligen Corporation $3.2M
26,172 sh across 3 lots
Exec May 15 2025
Filed May 16 2025 · 5:30 PM ET RGENSALE Repligen Corporation $3.4M
24,246 sh × $139.67
Exec Nov 21 2024
Filed Nov 22 2024 · 5:30 PM ET